for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

British American Tobacco PLC (ADR)

BTI.N

現在値

39.47USD

変化

0.16(+0.41%)

出来高

152,723

本日のレンジ

39.26

 - 

39.71

52週レンジ

27.33

 - 

45.63

∙ 約20分前の相場を表示しています。

適時開示

British American Tobacco Now Sees FY Adj Rev Growth In 1% To 3% Range

June 9 (Reuters) - British American Tobacco PLC <BATS.L>::BRITISH AM. TOBACCO - 2020 FIRST HALF PRE-CLOSE TRADING UPDATE.BAT - ANTICIPATE A FY20 CONSTANT CURRENCY ADJUSTED REVENUE GROWTH IN 1-3% RANGE..BAT - STRONG OPERATIONAL PERFORMANCE IS REFLECTED IN OUR CONTINUED COMMITMENT TO OUR 65% DIVIDEND PAY-OUT POLICY..BAT - IMPACT OF COVID-19 IN EMERGING MARKETS HAS BEEN MORE PRONOUNCED, INCLUDING IN BANGLADESH, VIETNAM AND MALAYSIA.BAT - CONTINUED COMMITMENT TO OUR 65% DIVIDEND PAY-OUT POLICY.BAT - GROWTH THIS YEAR WILL BE SLOWER.BAT - PRUDENT TO ANTICIPATE A FY20 CONSTANT CURRENCY ADJUSTED REVENUE GROWTH IN 1-3% RANGE.BAT - ANTICIPATE REACHING £5BN TARGET IN 2025.BAT - CLOSURES AND OTHER LOCK-DOWN MEASURES IN CERTAIN COUNTRIES, IN PARTICULAR SOUTH AFRICA, MEXICO AND ARGENTINA, HAVE PERSISTED LONGER THAN ANTICIPATED.BAT - ANTICIPATE, IN TOTAL, A FY HEADWIND OF C.3% FROM COVID-19 ON CONSTANT CURRENCY ADJUSTED REVENUE.BAT - H1 ADJUSTED DILUTED EPS IS EXPECTED TO BENEFIT FROM A REDUCED UNDERLYING TAX RATE AT H1.BAT - SEES MID-SINGLE FIGURE FY CONSTANT CURRENCY ADJUSTED DILUTED EPS GROWTH.BAT - PROGRESS TOWARDS 2025 AMBITION OF £5BN IN NEW CATEGORY REVENUE (PREVIOUSLY 2023/4).BAT - GLOBAL INDUSTRY CIGARETTE AND THP VOLUME, EXPECTED TO BE DOWN C.7% FOR FY.BAT - FY 2020 US INDUSTRY VOLUME EXPECTED TO BE DOWN C.4%.

BAT Says Its Potential COVID-19 Vaccine Shown To Produce Positive Immune Response

May 15 (Reuters) - British American Tobacco PLC <BATS.L>::BAT - UPDATES ON ITS BIOTECH UNIT KENTUCKY BIOPROCESSING DEVELOPING POTENTIAL VACCINE FOR COVID-19.BAT - POTENTIAL VACCINE HAS BEEN SHOWN TO PRODUCE A POSITIVE IMMUNE RESPONSE.BAT - VACCINE CANDIDATE NOW POISED TO PROGRESS TO NEXT STAGE WHICH WILL BE PHASE 1 HUMAN CLINICAL TRIALS PENDING FDA AUTHORISATION.BAT - CLINICAL TRIAL COULD START AS EARLY AS LATE JUNE, PENDING RESPONSES FROM RELEVANT HEALTH BODIES.BAT - INVESTED IN ADDITIONAL EQUIPMENT TO BOOST MANUFACTURING CAPABILITIES SHOULD THEY BE NEEDED.BAT - SUBMITTED PRE-INVESTIGATIVE NEW DRUG PACKAGE TO U.S. FDA WHO HAVE ACKNOWLEDGED SUBMISSION.BAT - CORRESPONDENCE WITH GOVERNMENT AGENCIES AROUND WORLD CONTINUES.

British American Tobacco Says DOJ, OFAC Investigations On Suspicions Of Sanctions Breach

April 14 (Reuters) - British American Tobacco PLC <BATS.L>::BAT - GROUP BEEN LIAISING WITH DOJ AND OFAC IN U.S., WHICH ARE CONDUCTING AN INVESTIGATION INTO SUSPICIONS OF BREACH OF SANCTIONS.BAT - COOPERATING WITH AUTHORITIES’ INVESTIGATIONS; AS INVESTIGATIONS ONGOING, "INAPPROPRIATE FOR US TO PROVIDE FURTHER COMMENT AT THIS TIME".

BAT Says Filed Patent Suits Against Philip Morris International Regarding IQOS Products

April 9 (Reuters) - British American Tobacco PLC <BATS.L>::BAT - FILED PATENT INFRINGEMENT CHALLENGES AGAINST PHILIP MORRIS INTERNATIONAL.BAT - HAVE BOUGHT 2 ACTIONS IN THE U.S. AGAINST PHILIP MORRIS – ONE VIA ITC AND ONE VIA EASTERN DISTRICT OF VIRGINIA COURT.BAT - FILED PATENT SUITS AGAINST PHILIP MORRIS INTERNATIONAL REGARDING IQOS PRODUCTS.BAT SAYS IS ASSERTING CO'S RIGHTS AGAINST PHILIP MORRIS GMBH AND PHILIP MORRIS PRODUCTS S.A. IN GERMANY.BAT SAYS IN THE UK, CO CHALLENGING THE VALIDITY OF PMI’S PATENT WHICH RELATES TO A HEATING MECHANISM EMPLOYING RESISTIVE HEATING TECHNOLOGY.

BAT Announces Pricing Of $2.40 Bln Notes Offering

March 31 (Reuters) - British American Tobacco PLC <BATS.L>::JSE: BTI - BRITISH AMERICAN TOBACCO ANNOUNCES PRICING OF $2,400,000,000 NOTES OFFERING.BAT - THAT B.A.T CAPITAL CORPORATION PRICED AN OFFERING OF $2,400,000,000 AGGREGATE PRINCIPAL AMOUNT OF GUARANTEED DEBT SECURITIES.BAT - INTENDS TO USE NET PROCEEDS OF OFFERING OF NOTES FOR GENERAL CORPORATE PURPOSES, INCLUDING POTENTIAL REPAYMENT OF UPCOMING MATURITIES.

Bat Capital Files For Three-Part, Notes Offering, Guaranteed By British American Tobacco PLC Size Not Disclosed - SEC Filing

March 30 (Reuters) - British American Tobacco PLC <BATS.L>::BAT CAPITAL CORP FILES FOR THREE-PART, NOTES OFFERING, GUARANTEED BY BRITISH AMERICAN TOBACCO PLC; SIZE NOT DISCLOSED - SEC FILING.

BAT Says Impact Of Coronavirus On Results Of Operations, Financial Condition Cannot Be Predicted

March 26 (Reuters) - British American Tobacco PLC <BATS.L>::IMPACT OF PRESENT CORONAVIRUS ON RESULTS OF OPERATIONS AND FINANCIAL CONDITION IS UNCERTAIN AND CANNOT BE PREDICTED.GROUP CONTINUES TO MONITOR DEVELOPMENTS CLOSELY AS COVID-19 PANDEMIC DEVELOPS.TO DATE, IMPACT OF COVID-19 PANDEMIC ON GROUP'S BUSINESS HAS NOT BEEN MATERIAL.

British American Tobacco Says Co Maintains FY Outlook For Constant Currency Adj Revenue Growth

March 18 (Reuters) - British American Tobacco PLC <BATS.L>::BRITISH AM. TOBACCO - BAT CAPITAL MARKETS WEBCAST.BAT - IN 2020 WE EXPECT TO MAKE FURTHER PROGRESS TOWARDS OUR AMBITION OF £5BN NEW CATEGORY REVENUE IN 2023/24.BAT - AS YET, WE HAVE SEEN NO MATERIAL IMPACT FROM COVID-19.BAT - OVERALL, DESPITE GLOBAL UNCERTAINTY, BUSINESS IS PERFORMING WELL.BAT - HAVE ALREADY ACHIEVED CLOSE TO 60% OF PRICING WE PLANNED FOR 2020.BAT - AT PRESENT MAINTAINING EXPECTATIONS FOR 2020 GLOBAL INDUSTRY CIGARETTE AND THP VOLUME TO BE DOWN C.4%.BAT - MAINTAIN OUR GUIDANCE FOR CONSTANT CURRENCY ADJUSTED REVENUE GROWTH OF 3-5% FOR YEAR.BAT - REMAIN COMMITTED TO A 65% DIVIDEND PAY-OUT RATIO ON ADJUSTED DILUTED EPS AND GROWTH IN STERLING TERMS.BAT - NOW EXPECT A HEADWIND OF LESS THAN 1% ON FULL YEAR ADJUSTED DILUTED EPS GROWTH, ALTHOUGH EXCHANGE RATES ARE CLEARLY VERY CHANGEABLE..BAT - EXPECT TO CONTINUE TO DELEVER BALANCE SHEET AND REMAIN COMMITTED TO A 65% DIVIDEND PAY-OUT RATIO ON ADJUSTED EPS AND GROWTH IN STERLING TERMS.BAT - £1BN OF EFFICIENCIES OVER NEXT THREE YEARS FROM AN EXTENDED PROJECT QUANTUM.BAT - EXPECT TO MAKE FURTHER PROGRESS TOWARDS AMBITION OF £5BN NEW CATEGORY REVENUE IN 2023/24..

British American Tobacco FY Revenue Rose 5.7% To 25.88 Billion Stg

Feb 27 (Reuters) - British American Tobacco PLC <BATS.L>::FY REVENUE ROSE 5.7 PERCENT TO 25.88 BILLION STG.FY DILUTED EPS FELL 5.4 PERCENT TO 249 PENCE.FY ADJUSTED DILUTED EPS ROSE 9.1 PERCENT TO 323.8 PENCE.ANTICIPATE GLOBAL INDUSTRY CIGARETTE AND THP VOLUME TO BE DOWN C.4%, WITH US INDUSTRY VOLUME DOWN C.5%, IN 2020.IN 2020, SEES HIGH SINGLE FIGURE ADJUSTED CONSTANT CURRENCY EARNINGS GROWTH.FY CIGARETTE AND THP VOLUME SHARE INCREASED BY 20BPS, WITH VALUE SHARE UP 30BPS IN KEY MARKETS.EXPECT 2020 ADJUSTED REVENUE GROWTH IN 3-5% GUIDANCE RANGE.EXPECT 2020 CONTINUED OPERATING MARGIN IMPROVEMENT AND FURTHER PROGRESS IN NEW CATEGORIES TOWARDS 2023/24 AMBITION OF £5BN IN REVENUE.2020 RESULTS, IN PARTICULAR NEW CATEGORY REVENUE GROWTH, WILL BE WEIGHTED TO SECOND HALF OF YEAR.EXPECT A HEADWIND OF AROUND 4% ON FULL YEAR ADJUSTED EPS GROWTH FOR 2020.DIVIDEND PER SHARE INCREASED 3.6% TO 210.4P, PAYABLE IN FOUR QUARTERLY DIVIDEND PAYMENTS OF 52.6P PER SHARE.FY ADJUSTED REVENUE OF £25,827M (UP 6.2%), OR £25,683M ON A CONSTANT CURRENCY BASIS (UP 5.6%).FY ADJUSTED PROFIT FROM OPERATIONS OF £11,130M (UP 7.6%), AN INCREASE OF 6.6% ON A CONSTANT CURRENCY BASIS.FY REPORTED PROFIT FROM OPERATIONS OF £9,016M DOWN 3.2% DRIVEN BY ADJUSTING ITEMS OF £2,114M (2018: £1,034M).INTENDED THAT RICHARD BURROWS WILL RETIRE FROM BOARD AT OR PRIOR TO ANNUAL GENERAL MEETING IN 2021 AND WILL CONTINUE TO LEAD BOARD IN INTERIM.

The Capital Group Companies Discloses 12.0049% Stake In BAT As Of Jan 3 Vs Prior Stake Of 11.0532% - Filing

Jan 7 (Reuters) - British American Tobacco PLC <BATS.L>::THE CAPITAL GROUP COMPANIES, INC. DISCLOSES 12.0049% STAKE IN BRITISH AMERICAN TOBACCO PLC AS OF JAN 3 VERSUS PRIOR STAKE OF 11.0532% - FILING.

金融情報はリフィニティブから。すべての情報は少なくとも20分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up